Zynnon AG

Pathogen detection and identification via gas biomarkers

Sepsis kills 11 million people yearly, with each hour of delayed treatment raising mortality risk by nearly 8%. Yet today’s gold standard diagnostic—blood culture—can take up to 48 hours, while sepsis can cause death in just 12. Inadequate antibiotics can reduce survival 5-fold, and misuse fuels Antimicrobial Resistance (AMR), projected to kill 10 million annually by 2050.
Zyn-Sepsis is a rapid, all-in-one in vitro diagnostic test for detecting and identifying bacterial pathogens in blood. It senses bacteria-specific gas biomarkers (VOCs) during their growth phase and applies machine learning to recognize unique VOC “fingerprints.” The result: fast, accurate identification in about 4 hours—with high sensitivity and specificity.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
Deal

26.09.2024

Tests in lab

Milestone

15.07.2024

Positive lab test results opening new microbiology markets

Show more...

No Jobs

No videos and documents

No Awards

Zynnon AG

Pathogen detection and identification via gas biomarkers

Headquarter:
Schindellegi

Foundation Date:
November 2019

Technology:

  • Medtech

Sectors:

  • Digital Health
  • Machine Learning / AI
  • Medical devices
  • Medtech